Ampio Pharmaceuticals, Inc. (AMPE): Price and Financial Metrics
AMPE Price/Volume Stats
| Current price | $0.01 | 52-week high | $7.47 |
| Prev. close | $0.00 | 52-week low | $0.00 |
| Day low | $0.00 | Volume | 400 |
| Day high | $0.01 | Avg. volume | 65,879 |
| 50-day MA | $0.01 | Dividend yield | N/A |
| 200-day MA | $0.85 | Market Cap | 11.35K |
AMPE Stock Price Chart Interactive Chart >
Ampio Pharmaceuticals, Inc. (AMPE) Company Bio
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. It is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds. The company's product pipeline includes Ampion, which is in phase III clinical trial, is an intra-articular injection for the treatment of osteoarthritis of the knee. Ampio Pharmaceuticals, Inc. has collaborative research agreements to explore new clinical indications for its immunomodulatory drug, Ampion. The company is headquartered in Englewood, Colorado.
AMPE Price Returns
| 1-mo | 354.55% |
| 3-mo | N/A |
| 6-mo | -96.00% |
| 1-year | -99.53% |
| 3-year | -100.00% |
| 5-year | -99.99% |
| YTD | -99.51% |
| 2023 | -54.48% |
| 2022 | -97.37% |
| 2021 | -64.15% |
| 2020 | 172.73% |
| 2019 | 47.59% |
Loading social stream, please wait...